L., Pawson, T., & Nagy, A
23 The recent wave of state Medicaid agencies withdrawing or restricting coverage for AOMs, particularly GLP-1s, reflects a unique tension between groundbreaking clinical efficacy, rapid uptake, optional coverage, and immediate fiscal reality
Offers broad-spectrum SPF 50 PA++++ protection against harmful UVA & UVB rays
We take time to learn about your unique health history and goals before crafting your personalized treatment plan
Bioanalysis 6 , 14451457 (2014)
*Correspondence: Hyunju Kang, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers